ATE318584T1 - Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol - Google Patents

Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol

Info

Publication number
ATE318584T1
ATE318584T1 AT02770107T AT02770107T ATE318584T1 AT E318584 T1 ATE318584 T1 AT E318584T1 AT 02770107 T AT02770107 T AT 02770107T AT 02770107 T AT02770107 T AT 02770107T AT E318584 T1 ATE318584 T1 AT E318584T1
Authority
AT
Austria
Prior art keywords
solvent
substance
liquid
crystalline particles
beclomethason
Prior art date
Application number
AT02770107T
Other languages
English (en)
Inventor
Martin John Mcloughlin
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE318584T1 publication Critical patent/ATE318584T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT02770107T 2001-10-25 2002-10-23 Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol ATE318584T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125604.9A GB0125604D0 (en) 2001-10-25 2001-10-25 Novel process

Publications (1)

Publication Number Publication Date
ATE318584T1 true ATE318584T1 (de) 2006-03-15

Family

ID=9924497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02770107T ATE318584T1 (de) 2001-10-25 2002-10-23 Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol

Country Status (8)

Country Link
US (1) US20040258756A1 (de)
EP (1) EP1438023B1 (de)
JP (1) JP4351532B2 (de)
AT (1) ATE318584T1 (de)
DE (1) DE60209516T2 (de)
ES (1) ES2258156T3 (de)
GB (1) GB0125604D0 (de)
WO (1) WO2003035035A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
SE0302029D0 (sv) * 2003-07-07 2003-07-07 Astrazeneca Ab Novel process
JP2005177746A (ja) * 2003-11-28 2005-07-07 Mitsubishi Chemicals Corp 有機化合物微粒子の製造方法
GB0406069D0 (en) * 2004-03-17 2004-04-21 Thompson James Process
CN101312713A (zh) * 2005-03-18 2008-11-26 纳米材料科技有限公司 可吸入的药物
JP4896418B2 (ja) * 2005-03-23 2012-03-14 富士フイルム株式会社 有機微粒子およびその分散液の製造方法、ならびにそれにより得られる有機微粒子およびその分散液
EP1868577A4 (de) 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipin-partikel
JP4870383B2 (ja) * 2005-05-06 2012-02-08 富士フイルム株式会社 ナノ粒子の濃縮方法
JP4993875B2 (ja) * 2005-05-06 2012-08-08 富士フイルム株式会社 凝集ナノ粒子の分散方法
US8679341B2 (en) * 2005-05-06 2014-03-25 Fujifilm Corporation Method of concentrating nanoparticles and method of deaggregating aggregated nanoparticles
KR101266569B1 (ko) 2005-05-09 2013-05-22 후지필름 가부시키가이샤 유기 입자 분산액의 제조 방법
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
US8052645B2 (en) 2008-07-23 2011-11-08 Avant Medical Corp. System and method for an injection using a syringe needle
MX384690B (es) 2008-05-20 2025-03-14 Avant Medical Corp Sistema auto-inyector.
PT105058B (pt) * 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
CN102058996A (zh) * 2010-10-29 2011-05-18 华侨大学 非溶剂法改进超临界抗溶剂过程制备药物超细微粒的方法
CA3021845C (en) 2011-04-20 2022-03-29 Amgen Inc. Autoinjector apparatus
WO2013009591A1 (en) * 2011-07-08 2013-01-17 Pfizer Limited Process for the preparation of fluticasone propionate form 1
USD898908S1 (en) 2012-04-20 2020-10-13 Amgen Inc. Pharmaceutical product cassette for an injection device
CN107880091B (zh) 2012-05-08 2020-12-18 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2705838A1 (de) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium-Zubereitungen
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
WO2014137982A1 (en) 2013-03-08 2014-09-12 The Board Of Trustees Of The University Of Illinois Ultrasonic method and apparatus for producing particles having a controlled size distribution
TWI580451B (zh) 2013-03-15 2017-05-01 安美基公司 用於注射器之匣盒及使用具有自動注射器及匣盒之自動注射器設備之方法
EP2968775B1 (de) 2013-03-15 2019-12-18 Amgen Inc. Medikamentenkassette, autoinjektor und autoinjektorsystem
CN104055741B (zh) * 2013-03-18 2017-02-15 青岛大学 一种孟鲁司特钠片剂及其制备方法
GB201402556D0 (en) 2014-02-13 2014-04-02 Crystec Ltd Improvements relating to inhalable particles
CN104771931B (zh) * 2015-04-20 2016-12-07 顾玉奎 一种中药超声提取装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855436A (en) * 1987-12-11 1989-08-08 Jet Research Center, Inc. Method of preparation of 2,6-bis(picrylamino)-3,5-dinitropyridine
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
FR2669635B1 (fr) * 1990-11-22 1994-06-10 Furchim Procede de fabrication d'hydroxymethylfurfural (hmf) du purete elevee.
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process

Also Published As

Publication number Publication date
ES2258156T3 (es) 2006-08-16
US20040258756A1 (en) 2004-12-23
WO2003035035A1 (en) 2003-05-01
EP1438023A1 (de) 2004-07-21
DE60209516T2 (de) 2006-08-10
JP4351532B2 (ja) 2009-10-28
GB0125604D0 (en) 2001-12-19
JP2005512763A (ja) 2005-05-12
DE60209516D1 (de) 2006-04-27
EP1438023B1 (de) 2006-03-01

Similar Documents

Publication Publication Date Title
DE60209516D1 (de) Prozess zur Herstellung kristalliner Partikel von Fluticason, Beclomethason, Salmeterol und Salbutamol
DE69830315D1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
SE8403427L (sv) Sett att framstella buten - l
ATE228828T1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
ATE364060T1 (de) Mikroporöse materialien und verfahren zu ihrer herstellung
WO2006055817A3 (en) Mixed matrix membrane with mesoporous particles and methods for making the same
BR0301946A (pt) Processo para separar um ou mais gases de uma mistura de gases, polìmero, e, poli(éster-imida)
ATE298889T1 (de) Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
SE9603303D0 (sv) Process for purifying a protein
DE69510937D1 (de) Verfahren zur gewinnung von polyhydroxyalkanoaten mittels zentrifugenfraktionerung
DE602004022752D1 (de) Verfahren zur Herstellung von einem monodispersen Schaum , und dadurch hergestelltes Produkt
DE502004007677D1 (de) Verfahren zur herstellung von propylenoxid
BR0104080A (pt) Leito adsorvente para uso na separação de um ou mais componentes de uma mistura dos gases da mistura gasosa, e, aparelhagem para carregamento de múltiplos adsorventes para dentro de um leito
ATE332297T1 (de) Verfahren zur herstellung von ascorbinsäure
WO2002022228A3 (en) Method for fractionating liquid mixtures
DE50107344D1 (de) Herstellung von polygalakturoniden und ihre verwendung als lebensmittelzusatzstoffe
DE50104094D1 (de) Verfahren zur Herstellung von reinem Triethylendiamin (TEDA)
SE9603304D0 (sv) Process for purifying a compound
ATE222920T1 (de) Ein kristall von diuridine tetraphosphat oder ein solches salz und verfahren zu seiner herstellung, verfahren und herstellung der vorgenannten zusammensetzung
RU95112488A (ru) Способ выделения энантиомеров из рацемической смеси
PE20050430A1 (es) Metodo para preparar un extracto de hojas de hiedra y extracto preparado segun este metodo
ATE235259T1 (de) Verfahren zur herstellung von kontrastmitteln
ATE490258T1 (de) Anwendung von zentrifugaler verteilungschromatographie zur aufreinigung von galanthamine
BR0206286A (pt) processo e dispositivo para separação de produtos de fermentação de baixa molecularidade de misturas de materiais

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties